Frank Tacke

TNFα-mediated liver destruction by Kupffer cells and Ly6Chi monocytes during Entamoeba histolytica infection.

Serum concentrations of A Proliferation-Inducing Ligand (APRIL) are elevated in sepsis and predict mortality in critically ill patients.

Circulating microRNA-150 serum levels predict survival in patients with critical illness and sepsis.

Protective effects of lipocalin-2 (LCN2) in acute liver injury suggest a novel function in liver homeostasis.

Elastin-based molecular MRI of liver fibrosis.

From NAFLD to NASH to fibrosis to HCC: role of dendritic cell populations in the liver.

Serum sodium based modification of the MELD does not improve prediction of outcome in acute liver failure.

Met-CCL5 modifies monocyte subpopulations during liver fibrosis regression.

Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis.

Overexpression of c-myc in hepatocytes promotes activation of hepatic stellate cells and facilitates the onset of liver fibrosis.

Frequency and phenotype of human circulating and intrahepatic natural killer cell subsets is differentially regulated according to stage of chronic liver disease.

YB-1 is an early and central mediator of bacterial and sterile inflammation in vivo.

Regulation and prognostic relevance of symmetric dimethylarginine serum concentrations in critical illness and sepsis.

Elevated asymmetric dimethylarginine levels predict short- and long-term mortality risk in critically ill patients.

Chemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis.

RIP3 inhibits inflammatory hepatocarcinogenesis but promotes cholestasis by controlling caspase-8- and JNK-dependent compensatory cell proliferation.

U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis.

HBV Subgenotypes D1, D2, D-del! Are 'Old' Genotyping Methods Interpreted Correctly?

Experimental liver fibrosis research: update on animal models, legal issues and translational aspects.

Macrophage heterogeneity in liver injury and fibrosis.

Levels of circulating miR-133a are elevated in sepsis and predict mortality in critically ill patients.

High prevalence of Y-box protein-1/p18 fragment in plasma of patients with malignancies of different origin.

Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C(+) macrophage infiltration in mice.

Role of lymphocytes in liver cancer.

CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis.

Eat more carrots? Dampening cell death in ethanol-induced liver fibrosis by β-carotene.

Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failure.

Liposomal encapsulation of dexamethasone modulates cytotoxicity, inflammatory cytokine response, and migratory properties of primary human macrophages.

Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea.

Translation control of TAK1 mRNA by hnRNP K modulates LPS-induced macrophage activation.

Role of gamma-delta T cells in liver inflammation and fibrosis.

GLP-1 secretion is increased by inflammatory stimuli in an IL-6-dependent manner, leading to hyperinsulinemia and blood glucose lowering.

A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis.

Molecular identification of hepatitis B virus genotypes/subgenotypes: revised classification hurdles and updated resolutions.

Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases.

Roles for chemokines in liver disease.

Interleukins in chronic liver disease: lessons learned from experimental mouse models.

Distinct patterns of IgG and IgA against food and microbial antigens in serum and feces of patients with inflammatory bowel diseases.

Cyclic adenosine monophosphate-responsive element modulator alpha overexpression impairs function of hepatic myeloid-derived suppressor cells and aggravates immune-mediated hepatitis in mice.

Pharmacological inhibition of the chemokine CXCL16 diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.

Variceal bleeding in liver cirrhosis at the ICU: sufficient data to treat adrenal insufficiency?*.

Fluorescent cell-traceable dexamethasone-loaded liposomes for the treatment of inflammatory liver diseases.

CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.

Reply: To PMID 24481979.

Liver immunology: new perspectives.

Immune mechanisms in acetaminophen-induced acute liver failure.

Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology.

Therapeutic targeting of liver inflammation and fibrosis by nanomedicine.